首页> 美国卫生研究院文献>BMC Immunology >Patient experience with subcutaneous immunoglobulin 20 Ig20Gly for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials

【2h】

Patient experience with subcutaneous immunoglobulin 20 Ig20Gly for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials

机译：皮下免疫球蛋白20％Ig20Gly的患者经验用于原发性免疫缺陷疾病：预先进行的事后分析对来自2个关键试验的综合数据进行事后分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Patient-reported outcomes collected in the Ig20Gly North American and European phase 2/3 trials

机译：在Ig20Gly北美和欧洲的2/3期临床试验中收集的患者报告的结果

著录项

期刊名称 BMC Immunology
作者
Lisa M. Meckley; Yanyu Wu; Diane Ito; Todd Berner; Barbara McCoy; Leman Yel;
展开▼
作者单位

展开▼
年(卷),期 2020(21),-1
年度 2020
页码 -1
总页数 15
原文格式 PDF
正文语种
中图分类免疫学;
关键词
Ig20Gly; Immunoglobulin; Subcutaneous; Satisfaction; Preference; Patient experience;

机译：Ig20Gly;免疫球蛋白;皮下;满意度;偏好;患者经验;

相似文献

外文文献
专利

1. Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials [J] . Lisa M. Meckley, Yanyu Wu, Diane Ito, BMC Immunology . 2020,第1期

机译：患者对皮下免疫球蛋白20％，Ig20gly的经验，用于原发性免疫缺陷疾病：从2个关痛试验中预先定义的组合数据后分析
2. Population pharmacokinetic modeling and simulation of immunoglobulin exposure with varying dosing intervals of subcutaneous immunoglobulin 20% (Ig20Gly) in patients with primary immunodeficiency diseases [J] . Dumas Todd, Berry N. Seth, Wolfsegger Martin, International immunopharmacology . 2019,第期

机译：初级免疫缺陷患者皮下免疫球蛋白20％（Ig20gly）不同给药间隔的人口药代动力学建模与仿真性间隔
3. Interim Analysis of the Global Post Authorization Safety Study of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Treatment in Patients With Primary Immunodeficiency Diseases [J] . Rubinstein Arye, Bridges Tracy, McNeil Donald, Journal of Clinical Immunology . 2018,第3期

机译：透析酶促进皮下免疫球蛋白10％治疗初级免疫缺陷患者的临时分析
4. An evaluation of the budget impact of a new 20 subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland [O] . Richard F Pollock, Lisa M Meckley 2018

机译：评估新型20％皮下免疫球蛋白（Ig20Gly）对瑞士原发性免疫缺陷疾病管理的预算影响
5. Patient experience with subcutaneous immunoglobulin 20, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials [O] . Lisa M. Meckley, Yanyu Wu, Diane Ito, 2020

机译：患者对皮下免疫球蛋白20％，Ig20gly的经验，用于原发性免疫缺陷疾病：从2个关痛试验中预先定义的组合数据后分析

Patient experience with subcutaneous immunoglobulin 20 Ig20Gly for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials

摘要

著录项

相似文献

相关主题

期刊订阅